Comments
U.S. delays decision on Takeda diabetes drug
26.04.2012. | (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said U.S. regulators had extended their review of its diabetes drug alogliptin, requesting additional data on what the company hopes will be the successor to its top-selling Actos drug....
